MoneyWorks4Me

Lyka Labs informs about outcome of board meeting

04 Feb 2025 Evaluate
Lyka Labs has informed that the Board of Directors of the Company at its meeting held today i.e. 4th February, 2025, has considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December, 2024 and the said Financial Results have been reviewed by the Audit Committee. In this regard, a copy of the said Financial Results along with the Limited Review Reports of the Auditors of the Company thereon is enclosed. These are also being made available on the website of the Company at www.lykalabs.com. The meeting of the Board of Directors commenced at 1.15 pm and concluded at 3:05 pm.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1850.00
Dr. Reddys Labs. 1202.70
Cipla 1399.50
Lupin 2094.45
Zydus Lifesciences 1186.05
View more..